[HTML] frontiersin.org

[HTML][HTML] The multiple sclerosis prodrome: evidence to action

H Tremlett, KL Munger, N Makhani - Frontiers in Neurology, 2022 - frontiersin.org
A growing body of work points toward the existence of a clinically symptomatic prodromal
phase in multiple sclerosis (MS) that might span 5–10 years or more. A prodrome is an early …
被引用次数：26 相关文章

The Multiple Sclerosis Prodrome: Evidence to Action

H Tremlett, KL Munger… - Frontiers in neurology, 2022 - pubmed.ncbi.nlm.nih.gov
A growing body of work points toward the existence of a clinically symptomatic prodromal
phase in multiple sclerosis (MS) that might span 5-10 years or more. A prodrome is an early …

The Multiple Sclerosis Prodrome: Evidence to Action

H Tremlett, KL Munger, N Makhani - Preventing Multiple …, 2022 - books.google.com
A growing body of work points toward the existence of a clinically symptomatic prodromal
phase in multiple sclerosis (MS) that might span 5–10 years or more. A prodrome is an early …
[HTML] nih.gov

[HTML][HTML] The Multiple Sclerosis Prodrome: Evidence to Action

H Tremlett, KL Munger, N Makhani - Frontiers in Neurology, 2021 - ncbi.nlm.nih.gov
A growing body of work points toward the existence of a clinically symptomatic prodromal
phase in multiple sclerosis (MS) that might span 5–10 years or more. A prodrome is an early …

The Multiple Sclerosis Prodrome: Evidence to Action.

H Tremlett, KL Munger, N Makhani - Frontiers in Neurology, 2022 - europepmc.org
A growing body of work points toward the existence of a clinically symptomatic prodromal
phase in multiple sclerosis (MS) that might span 5–10 years or more. A prodrome is an early …

The Multiple Sclerosis Prodrome: Evidence to Action.

H Tremlett, KL Munger, N Makhani - Frontiers in Neurology, 2022 - europepmc.org
A growing body of work points toward the existence of a clinically symptomatic prodromal
phase in multiple sclerosis (MS) that might span 5–10 years or more. A prodrome is an early …